Real-Time AI-Driven Decision Support Aids Catheter Ablation
By Lori Solomon HealthDay Reporter
WEDNESDAY, May 7, 2025 -- An artificial intelligence (AI)-driven model can significantly improve procedural safety in cardiac electrophysiology with real-time decision support, according to a study presented at the annual meeting of the Heart Rhythm Society, held from April 24 to 27 in San Diego.
Chih-Min Liu, M.D., Ph.D., from Taipei Veterans General Hospital in Taiwan, and colleagues developed the DeePRISM model using retrospective data from 110 patients with persistent atrial fibrillation (AF), incorporating deep learning and PRISM (Morphological Repetitiveness by Periodicity and Similarity) analysis to analyze intracardiac electrograms and predict AF termination sites during catheter ablation. An additional 37 patients with persistent AF were used to prospectively validate the model.
The researchers found that the DeePRISM model achieved strong performance in the independent test set with an area under the curve of 0.87 (sensitivity, 74.3 percent, specificity, 95.4 percent, overall accuracy, 95.4 percent). Roughly four in 10 patients (40.5 percent) achieved acute AF termination when undergoing DeePRISM-guided ablation. During a mean follow-up of 27.3 months, the DeePRISM group had significantly superior arrhythmia-free survival versus controls (70.3 versus 35.1 percent). Additionally, DeePRISM-guided ablation significantly reduced the risk for AF recurrence (hazard ratio, 0.10) without any periprocedural complications.
"With the introduction of the DeePRISM model, we are taking a significant step forward in the treatment of persistent atrial fibrillation," Liu said in a statement. "Our study shows that AI-driven, real-time analysis not only enhances the success of the procedure but also ensures patient safety, marking a promising advance in electrophysiology."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted May 2025
Read this next
Consistent Physical Activity Linked to Reduced All-Cause, CVD Mortality
FRIDAY, July 11, 2025 -- Consistently and increasingly accumulated physical activity (PA) is associated with a reduced risk for all-cause and cardiovascular disease (CVD)...
Almost 15 Percent of U.S. Seniors Use Aspirin for Primary Prevention
THURSDAY, July 10, 2025 -- Almost 15 percent of U.S. adults aged 50 to 80 years are taking aspirin for primary cardiovascular disease prevention, according to a brief report...
A-Fib Catheter Ablation Cuts Risk for Ischemic Stroke After 30 Days, Mortality, Heart Failure Hospitalization
MONDAY, July 7, 2025 -- For patients with atrial fibrillation, catheter ablation reduces the risks for ischemic stroke at more than 30 days, mortality, and heart failure...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.